GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (STU:2HE) » Definitions » 3-Year EBITDA Growth Rate

HealthEquity (STU:2HE) 3-Year EBITDA Growth Rate : 16.80% (As of Jul. 2024)


View and export this data going back to 2018. Start your Free Trial

What is HealthEquity 3-Year EBITDA Growth Rate?

HealthEquity's EBITDA per Share for the three months ended in Jul. 2024 was €1.10.

During the past 12 months, HealthEquity's average EBITDA Per Share Growth Rate was 44.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 16.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 11.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of HealthEquity was 38.50% per year. The lowest was -31.30% per year. And the median was 22.80% per year.


Competitive Comparison of HealthEquity's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, HealthEquity's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where HealthEquity's 3-Year EBITDA Growth Rate falls into.



HealthEquity 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


HealthEquity  (STU:2HE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


HealthEquity 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of HealthEquity's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

HealthEquity Headlines

No Headlines